Stratec Se (SBSG)

Currency in EUR
28.600
+1.250(+4.57%)
Closed·
Advertisement
Trading near 52-week High
SBSG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
28.20029.850
52 wk Range
16.30029.850
Key Statistics
Bid/Ask
28.60 / 28.90
Prev. Close
28.6
Open
28.55
Day's Range
28.2-29.85
52 wk Range
16.3-29.85
Volume
51.3K
Average Volume (3m)
15.73K
1-Year Change
41.9355%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SBSG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
33.200
Upside
+16.08%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Stratec Se News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

5 Buy
1 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 33.200
(+16.08% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Deutsche Bank
Buy39.00+36.36%21.00Upgrade19/11/2026
Berenberg
Buy39.00+36.36%37.00Maintain04/11/2026
Berenberg
Buy37.00+29.37%-Maintain30/06/2026
Kepler Cheuvreux
Buy26.00-9.09%29.00Maintain26/05/2026
Deutsche Bank
Hold21.00-26.57%23.00Maintain04/05/2026

Stratec Se Earnings Call Summary for Q3/2026

  • Nine-month revenue fell 6.1% to EUR 165M, but adjusted EBIT rose 6.5% to EUR 13.7M with margin expanding to 8.3% from 7.3% year-over-year.
  • Q3 showed strong momentum with adjusted EBIT up 37% and margin hitting 11.3%, a 370 basis point improvement driven by cost control and product mix.
  • Free cash flow swung to positive EUR 30.6M from negative EUR 14.8M; core platforms including molecular/immunoassay systems grew double digits.
  • Stratec signed agreement to divest Diatron hematology unit to Indian investors, refocusing on high-end automated systems for U.S., Europe, Asia markets.
  • Management raised 2026 adjusted EBIT margin target to 13-15%, expects stable to slightly higher revenue versus pro forma EUR 223.5M excluding Diatron.
Last Updated: 12/11/2026, 14:38
Read Full Transcript

Earnings

Latest Release
12/11/2026
EPS / Forecast
-2.92 / 0.36
Revenue / Forecast
52.4M / 63M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -3.49
Dividend Yield
2.10%
Industry Median 1.70%
Annualised payout
0.60
Paid annually
5-Years Growth
-7.79%
Growth Streak

Compare SBSG to Peers and Sector

Metrics to compare
SBSG
Peers
Sector
Relationship
P/E Ratio
−8.2x2.8x−0.2x
PEG Ratio
0.020.030.00
Price/Book
1.8x1.3x2.6x
Price / LTM Sales
1.4x1.6x2.7x
Upside (Analyst Target)
16.1%39.6%72.2%
Fair Value Upside
Unlock11.3%12.4%Unlock

Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

Employees
1352
Market
Germany

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
2.73M22.45%74.62M
Other Institutional Investors
2.98M24.48%81.38M
Public Companies & Retail Investors
6.45M53.08%176.46M
Total
12.16M100.00%332.47M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
The Brown Capital Management International Small Company Fund5.20%632,46917,298
Morgan Stanley5.10%619,37516,940

People Also Watch

11.660
MLPG
+0.34%
33.050
IXXG
-0.45%
19.500
M12
+2.20%
2.070
HPHA
+0.49%
4.880
MPCG
-1.41%

FAQ

What Is the Stratec (Xetra: SBSG) Share Price Today?

The Stratec stock price today is 28.600 EUR.

What Stock Exchange Does Stratec (SBSG) Trade On?

Stratec is listed and trades on the Frankfurt Stock Exchange.

What Is the Ticker (Stock Symbol) for Stratec?

The stock symbol (also called a 'ticker') for Stratec is "SBSG."

Does Stratec Pay Dividends? What’s The Current SBSG Dividend Yield?

Yes, SBSG Pays Dividends to its Shareholders. The current Stratec dividend yield is 2.1%%.

What Is the Current Stratec Market Capitalisation?

As of today, Stratec (Xetra: SBSG) market cap is 347.660M EUR.

What Is Stratec's (SBSG) Earnings Per Share (TTM)?

The Stratec EPS is currently -3.49 (Trailing Twelve Months).

When Is the Next Stratec Earnings Date?

Stratec's next earnings report will be released on 31/03/2027.

Is SBSG a Buy or Sell From a Technical Analyst Perspective?

Based on today's Stratec moving averages and other technical indicators, the daily buy/sell signal for SBSG stock is Strong Buy.

How Many Times Has Stratec Stock Split?

Stratec has split 1 times. (See the SBSG stock split history page for full effective split date and price information.)

How Many Employees Does Stratec Have?

Stratec has 1352 employees, based on their latest Companies House report.

What is the current trading status of Stratec (Xetra: SBSG)?

As of 20/11/2026, Stratec (SBSG) is trading at a share price of 28.600 EUR, with a previous close of 28.600 EUR. The stock has fluctuated within a day range of 28.200 EUR to 29.850 EUR, while its 52-week range spans from 16.300 EUR to 29.850 EUR.

What Is Stratec (SBSG) Price Target According to Analysts?

The average 12-month price target for Stratec is 33.200 EUR, with a high estimate of 39 EUR and a low estimate of 26 EUR. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +16.08% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.